Funding newsPublished July 22, 2026

A.D.A.M. Innovations

Recently funded · $5.0M Series aHospitals and Health CareJPView source

Get the full A.D.A.M. Innovations (formerly Genesis Healthcare – GeneLife) company profile

Access contacts, investors, buying signals & more

The Tokyo-based firm behind Japan's largest R&D genomic database, A.D.A.M. Innovations, has secured $5.0M in Series A funding. Formerly operating as Genesis Healthcare – GeneLife, the company is a pioneer in genomics, AI, and precision health solutions.

A.D.A.M. Innovations develops cutting-edge technologies across consumer genetics, clinical diagnostics, and AI-driven R&D data platforms. To date, the company has completed more than 2.9 million genetic tests, leveraging its extensive data to advance precision health.

Other Japan companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#	Company	Round	Amount	Date
1	Shockwave Medical United States	Unknown	$13.1B	1y ago
2	NeuroEM Therapeutics United States	Unknown

Other recent Series a rounds

Companies that recently closed a Series a round.

#	Company	Round	Amount	Date
1	QLogic Entertainment United States	Series a	$25.0M	today
2	TurtleTree United States	Series a	$1.0M	today

A.D.A.M. Innovations

Other Japan companies recently funded

Biggest recent Biotechnology rounds

Other recent Series a rounds

Unlock A.D.A.M. Innovations (formerly Genesis Healthcare – GeneLife)'s full profile

Investors

Key decision-makers

Similar recently funded companies